Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Enzymatic versatility of the salmonella effector SopB enables manipulation of host phosphoinositide signalling.

Created on 04 Sep 2026

Authors

Ronan C Jensen, Gregory D Fairn

Published in

Discover bacteria. Volume 3. Issue 1. Pages 19. Epub Aug 22, 2026.

Abstract

Salmonella enterica relies on type III secreted effector proteins to invade host cells and establish an intracellular replicative niche, the Salmonella-containing vacuole (SCV). Among these effectors, SopB (also known as SigD) is notable for its functional versatility, contributing to virtually every stage of infection. Long characterized as a phosphoinositide phosphatase and inositol polyphosphate phosphatase, SopB was recently shown to also possess phosphotransferase activity, generating PtdIns(3,4)P2 (and, transiently, PtdIns(3,4,5)P3) de novo from PtdIns(4,5)P2 independently of PI 3-kinases and ATP. This discovery reframes how SopB activates the pro-survival kinase Akt and manipulates host signalling during invasion. Beyond its enzymatic activities, SopB engages the host Rho GTPases Cdc42 through a structurally distinct N-terminal domain and reorganizes the vimentin intermediate filament network to stabilize the SCV. In this review, we consider SopB as a paradigm for multifunctional effector biology, integrating its dual enzymatic activities, vimentin manipulation, anti-apoptotic signalling, and post-translational regulation into a unified model of how a single bacterial protein rewires host phosphoinositide metabolism across space and time.

PMID:
42694984
Bibliographic data and abstract were imported from PubMed on 04 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement